Developer docs
API playgroundTry for free, no card

Search company profiles

Nano Diagnostics

Full company profile

uuid000zir6

Namestring
Nano Diagnostics
Legal namestring
Nano Diagnostics, LLC
Websiteurl
nanodiaincs.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

Nano Diagnostics is a privately held biotechnology company organized as Nano Diagnostics, LLC under California jurisdiction and headquartered at 1751 Fortune Drive, unit G3, San Jose, California. The company's stated focus is developing diagnostic products for pathogen detection, placing it within the in-vitro diagnostics / clinical microbiology segment of the life sciences industry. It was founded in 2004 and operates from a single San Jose location, with no additional offices, subsidiaries, or parent-company structure disclosed.

The firm's digital surface area is minimal: a corporate website at nanodiaincs.com with a homepage, a products page, and a contact line. The products page exists but the product catalog table is empty, displaying "No Data" rather than enumerated SKUs, catalog numbers, or technical descriptions. No underlying diagnostic platform architecture, assay chemistry, instrumentation, regulatory filings (e.g., FDA 510(k), CE-IVD), patents, certifications, or technology integrations are disclosed in the available source material. There is no evidence of API exposure, SDK distribution, or third-party integrations.

The business model is not articulated in available sources. No pricing model, go-to-market channels, distribution arrangements, named customers, or revenue mechanics are disclosed. Workforce is reported at 1-10 employees, no management team or leadership roster is published, and there are no funding rounds, investors, or M&A activity on record. The only verifiable signal of recent activity is a news post on the company website dated June 29, 2026, the content of which is not fully captured, indicating continued but low-velocity operations rather than active commercial scaling.

Short descriptiontext

Nano Diagnostics is a San Jose, California-based biotechnology LLC focused on developing diagnostic products for pathogen detection. Founded in 2004, the privately held firm operates with 1-10 employees from a single headquarters and maintains an informational web presence without disclosed products, customers, or revenue mechanics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFayetteville, United States
HQ citystring
Fayetteville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pathogen detection products, molecular diagnostics kits, infectious disease testing, biotechnology diagnostics, diagnostic reagents
Industry3 codes
PRIMARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code2 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Research and Development in Nanotechnology541713
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics
Social media profiles1 record
Cost components3 values
Personnel, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nano Diagnostics is a biotechnology company that develops diagnostic products aimed at pathogen detection. The company operates a small-scale operation focused on providing diagnostic solutions to its customers. Specific product catalog items are not enumerated on the company's website at this time.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Nano Diagnostics appears to offer diagnostic products or services, though the specific product portfolio is not enumerated in the available source material. The company's products page exists at https://www.nanodiaincs.com/products but displays no product listings in the scraped content.

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cepheid, owned by Danaher, pioneered the GeneXpert molecular diagnostics platform widely used for pathogen detection including tuberculosis, MRSA, and respiratory pathogens. Directly comparable in pathogen-detection molecular diagnostics at a much larger commercial scale.

TypeEmerging player
Description

T2 Biosystems develops molecular diagnostics using T2 Magnetic Resonance (T2MR) technology for direct-from-blood pathogen detection. Comparable as a smaller-scale pathogen-detection diagnostics company, with somewhat similar operational scale challenges.

TypeEmerging player
Description

Mesa Labs offers diagnostics and quality control products across multiple niches including clinical microbiology. Somewhat comparable as a smaller-scale diagnostics company serving laboratory and clinical customers.

TypeEmerging player
Description

Binx Health provides rapid molecular point-of-care diagnostics, including for sexually transmitted infections. Comparable as a smaller molecular diagnostics player developing rapid pathogen-detection products, somewhat similar in scale and stage.

TypeEmerging player
Description

Specific Diagnostics develops rapid antimicrobial susceptibility testing and pathogen identification products using metabolomic signatures. Comparable as a smaller-scale, growth-stage molecular diagnostics company focused on infectious disease.

TypeBroad incumbent
Description

Hologic's Panther system and Panther Fusion offer molecular diagnostics for women's health and infectious disease pathogens. Comparable as a diagnostics incumbent serving clinical laboratories with pathogen-detection products.

TypeBroad incumbent
Description

BioFire, a subsidiary of bioMérieux, is a leader in molecular diagnostics for pathogen detection with its FilmArray system widely used in clinical labs. Directly comparable as a pathogen-detection diagnostics company, though vastly larger and more established than Nano Diagnostics.

TypeEmerging player
Description

Accelerate Diagnostics provides rapid pathogen identification and antimicrobial susceptibility testing, including the Accelerate Pheno system. Comparable as a small-to-mid scale pathogen diagnostics player focused on clinical microbiology.

TypeBroad incumbent
Description

GenMark, now part of Roche, develops multiplex molecular diagnostic tests for respiratory pathogens and bloodstream infections using its ePlex system. Closely comparable in multiplex pathogen detection diagnostics.

TypeBroad incumbent
Description

QIAGEN is a major molecular diagnostics and sample technologies company with broad pathogen-detection offerings including the QIAstat-Dx system. Relevant as a broad incumbent in the molecular diagnostics space that includes pathogen detection.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nano Diagnostics

In Vitro Diagnosticsnanodiaincs.com

Nano Diagnostics is a San Jose, California-based biotechnology LLC focused on developing diagnostic products for pathogen detection. Founded in 2004, the privately held firm operates with 1-10 employees from a single headquarters and maintains an informational web presence without disclosed products, customers, or revenue mechanics.

What Nano Diagnostics does

Nano Diagnostics is a privately held biotechnology company organized as Nano Diagnostics, LLC under California jurisdiction and headquartered at 1751 Fortune Drive, unit G3, San Jose, California. The company's stated focus is developing diagnostic products for pathogen detection, placing it within the in-vitro diagnostics / clinical microbiology segment of the life sciences industry. It was founded in 2004 and operates from a single San Jose location, with no additional offices, subsidiaries, or parent-company structure disclosed.

The firm's digital surface area is minimal: a corporate website at nanodiaincs.com with a homepage, a products page, and a contact line. The products page exists but the product catalog table is empty, displaying "No Data" rather than enumerated SKUs, catalog numbers, or technical descriptions. No underlying diagnostic platform architecture, assay chemistry, instrumentation, regulatory filings (e.g., FDA 510(k), CE-IVD), patents, certifications, or technology integrations are disclosed in the available source material. There is no evidence of API exposure, SDK distribution, or third-party integrations.

The business model is not articulated in available sources. No pricing model, go-to-market channels, distribution arrangements, named customers, or revenue mechanics are disclosed. Workforce is reported at 1-10 employees, no management team or leadership roster is published, and there are no funding rounds, investors, or M&A activity on record. The only verifiable signal of recent activity is a news post on the company website dated June 29, 2026, the content of which is not fully captured, indicating continued but low-velocity operations rather than active commercial scaling.

Nano Diagnostics firmographics

Firmographics
Name
Nano Diagnostics
Legal name
Nano Diagnostics, LLC
Website
https://nanodiaincs.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
Nano Diagnostics is a San Jose, California-based biotechnology LLC focused on developing diagnostic products for pathogen detection. Founded in 2004, the privately held firm operates with 1-10 employees from a single headquarters and maintains an informational web presence without disclosed products, customers, or revenue mechanics.
Ownership category
akta.pro rank

Nano Diagnostics industry classification

Industry
Product category
In Vitro Diagnostics
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Nanotechnology (541713)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
SECONDARYHDAHALAK
Biosensors & Lab-on-Chip (BioMEMS)
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Pathogen detection products
  • Molecular diagnostics kits
  • Infectious disease testing
  • Biotechnology diagnostics
  • Diagnostic reagents

Where Nano Diagnostics is headquartered

Location

Headquarters

HQ city
Fayetteville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Nano Diagnostics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations

Nano Diagnostics product offering

Product offering

Core offering

Nano Diagnostics is a biotechnology company that develops diagnostic products aimed at pathogen detection. The company operates a small-scale operation focused on providing diagnostic solutions to its customers. Specific product catalog items are not enumerated on the company's website at this time.

Product overview

Nano Diagnostics appears to offer diagnostic products or services, though the specific product portfolio is not enumerated in the available source material. The company's products page exists at https://www.nanodiaincs.com/products but displays no product listings in the scraped content.

Differentiator

Problem solved

Functional benefit

Companies that use Nano Diagnostics

Customer profile

Ideal customer profiles1 record

Nano Diagnostics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Nano Diagnostics partnerships and signals

Strategic signal

Recent moves3 records

Expansion highlights2 records

Nano Diagnostics competitors and assessment

Company assessment

Broad incumbents

  • Cepheid (Danaher): Cepheid, owned by Danaher, pioneered the GeneXpert molecular diagnostics platform widely used for pathogen detection including tuberculosis, MRSA, and respiratory pathogens. Directly comparable in pathogen-detection molecular diagnostics at a much larger commercial scale.
  • Hologic: Hologic's Panther system and Panther Fusion offer molecular diagnostics for women's health and infectious disease pathogens. Comparable as a diagnostics incumbent serving clinical laboratories with pathogen-detection products.
  • BioFire Diagnostics (bioMérieux): BioFire, a subsidiary of bioMérieux, is a leader in molecular diagnostics for pathogen detection with its FilmArray system widely used in clinical labs. Directly comparable as a pathogen-detection diagnostics company, though vastly larger and more established than Nano Diagnostics.
  • GenMark Diagnostics (Roche): GenMark, now part of Roche, develops multiplex molecular diagnostic tests for respiratory pathogens and bloodstream infections using its ePlex system. Closely comparable in multiplex pathogen detection diagnostics.
  • QIAGEN: QIAGEN is a major molecular diagnostics and sample technologies company with broad pathogen-detection offerings including the QIAstat-Dx system. Relevant as a broad incumbent in the molecular diagnostics space that includes pathogen detection.

Emerging players

  • T2 Biosystems: T2 Biosystems develops molecular diagnostics using T2 Magnetic Resonance (T2MR) technology for direct-from-blood pathogen detection. Comparable as a smaller-scale pathogen-detection diagnostics company, with somewhat similar operational scale challenges.
  • Mesa Labs: Mesa Labs offers diagnostics and quality control products across multiple niches including clinical microbiology. Somewhat comparable as a smaller-scale diagnostics company serving laboratory and clinical customers.
  • Binx Health: Binx Health provides rapid molecular point-of-care diagnostics, including for sexually transmitted infections. Comparable as a smaller molecular diagnostics player developing rapid pathogen-detection products, somewhat similar in scale and stage.
  • Specific Diagnostics: Specific Diagnostics develops rapid antimicrobial susceptibility testing and pathogen identification products using metabolomic signatures. Comparable as a smaller-scale, growth-stage molecular diagnostics company focused on infectious disease.
  • Accelerate Diagnostics: Accelerate Diagnostics provides rapid pathogen identification and antimicrobial susceptibility testing, including the Accelerate Pheno system. Comparable as a small-to-mid scale pathogen diagnostics player focused on clinical microbiology.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat1 record

Key risks6 records

Key highlights3 records

Customer concentration

Nano Diagnostics social profiles

Digital presence

Nano Diagnostics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nano Diagnostics leadership team

Management profile

Number of profiles

Nano Diagnostics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nano Diagnostics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nano Diagnostics

What does Nano Diagnostics do?

Nano Diagnostics is a biotechnology company that develops diagnostic products aimed at pathogen detection. The company operates a small-scale operation focused on providing diagnostic solutions to its customers. Specific product catalog items are not enumerated on the company's website at this time.

Is Nano Diagnostics a public or private company?

Nano Diagnostics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Nano Diagnostics founded?

Nano Diagnostics was founded in 2007. It employs 1 to 10 people.

Where is Nano Diagnostics based?

Nano Diagnostics is headquartered in Fayetteville, United States, in the North America region.

Who are Nano Diagnostics's main competitors?

Broad incumbents on record are Cepheid (Danaher), Hologic, BioFire Diagnostics (bioMérieux), GenMark Diagnostics (Roche) and QIAGEN. Emerging players are T2 Biosystems, Mesa Labs, Binx Health, Specific Diagnostics and Accelerate Diagnostics.

Does Nano Diagnostics have an API?

No public API is recorded for Nano Diagnostics.

What industry is Nano Diagnostics in?

Nano Diagnostics's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays), with a secondary code of HDAHALAK, Biosensors & Lab-on-Chip (BioMEMS). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales